Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Factor XII: what does it contribute to our understanding of the physiology and  pathophysiology of hemostasis & thrombosis Stavrou E; Schmaier AHThromb Res  2010[Mar]; 125 (3): 210-5Factor XII (FXII) is a coagulation protein that is essential for  surface-activated blood coagulation tests but whose deficiency is not associated  with bleeding. For over forty years, investigators in hemostasis have not  considered FXII important because its deficiency is not associated with bleeding.  It is because there is a dichotomy between abnormal laboratory assay findings due  to FXII deficiency and clinical hemostasis that investigators sought explanations  for physiologic hemostasis independent of FXII. FXII is a multidomain protein  that contains two fibronectin binding consensual sequences, two epidermal growth  factor regions, a kringle region, a proline-rich domain, and a catalytic domain  that when proteolyzed turns into a plasma serine protease. Recent investigations  with FXII deleted mice that are protected from thrombosis indicate that it  contributes to the extent of developing thrombus in the intravascular  compartment. These findings suggest that it has a role in thrombus formation  without influencing hemostasis. Last, FXII has been newly appreciated to be a  growth factor that may influence tissue injury repair and angiogenesis. These  combined studies suggest that FXII may become a pharmacologic target to reduce  arterial thrombosis risk and promote cell repair after injury, without  influencing hemostasis.|Animals[MESH]|Blood Coagulation/physiology[MESH]|Factor XII Deficiency/metabolism[MESH]|Factor XII/*physiology[MESH]|Hemostasis/*physiology[MESH]|Mice[MESH]|Thrombosis/*metabolism[MESH] |